These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Pharmacodynamics and pharmacokinetics of disopyramide phosphate]. Ol'binskaia LI; Tiukavkina NA; Kuz'mina MM; Beloborodov VL; Klimov AV Farmakol Toksikol; 1985; 48(4):73-8. PubMed ID: 3930285 [TBL] [Abstract][Full Text] [Related]
44. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. Le Corre P; Gibassier D; Sado P; Le Verge R Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466 [TBL] [Abstract][Full Text] [Related]
45. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Heel RC; Brogden RN; Speight TM; Avery GS Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555 [TBL] [Abstract][Full Text] [Related]
46. Stereoselective disposition and metabolism of disopyramide in pediatric patients. Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088 [TBL] [Abstract][Full Text] [Related]
47. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients. Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151 [TBL] [Abstract][Full Text] [Related]
48. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia. Hulting J; Rosenhamer G Acta Med Scand; 1976; 199(1-2):41-51. PubMed ID: 1251772 [TBL] [Abstract][Full Text] [Related]
49. Clinical pharmacokinetics of controlled-release disopyramide in patients with cardiac arrhythmias. Capparelli EV; DiPersio DM; Zhao H; Kluger J; Chow MS J Clin Pharmacol; 1988 Apr; 28(4):306-11. PubMed ID: 3392228 [TBL] [Abstract][Full Text] [Related]
58. Bioavailability of disopyramide in normal volunteers using unbound concentration. Braun J; Sörgel F; Gluth WP; Oie S Eur J Clin Pharmacol; 1987; 32(6):625-9. PubMed ID: 3653232 [TBL] [Abstract][Full Text] [Related]
59. The effect of enzyme induction on the metabolism of disopyramide in man. Aitio ML; Mansury L; Tala E; Haataja M; Aitio A Br J Clin Pharmacol; 1981 Mar; 11(3):279-85. PubMed ID: 7213529 [TBL] [Abstract][Full Text] [Related]
60. Maintenance therapy after i.v. administration of disopyramide with an oral sustained release preparation, a pharmacokinetic study. Liem KL; Hollander JM Br J Clin Pharmacol; 1984 Aug; 18(2):226-8. PubMed ID: 6487461 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]